Cargando…

Association of Immune Semaphorins with COVID-19 Severity and Outcomes

Semaphorins have recently been recognized as crucial modulators of immune responses. In the pathogenesis of COVID-19, the activation of immune responses is the key factor in the development of severe disease. This study aimed to determine the association of serum semaphorin concentrations with COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vargovic, Martina, Papic, Neven, Samadan, Lara, Balen Topic, Mirjana, Vince, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604420/ https://www.ncbi.nlm.nih.gov/pubmed/37893159 http://dx.doi.org/10.3390/biomedicines11102786

Ejemplares similares

1347. Do Class 3 Semaphorins Play a Role in COVID-19 Outcomes in Patients with Non-alcoholic Fatty Liver Disease?
por: Vargovic, Martina, et al.
Publicado: (2023)

311. Impact of Non-alcoholic Fatty Liver Disease on Clinical Outcomes in Patients with COVID-19
por: Vrsaljko, Nina, et al.
Publicado: (2021)

Do Semaphorins Play a Role in Development of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease?
por: Šamadan, Lara, et al.
Publicado: (2022)

Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study
por: Vrsaljko, Nina, et al.
Publicado: (2022)

Unresolved issues in hepatitis C: The role of liver non-parenchymal cells and semaphorins
por: Vince, Adriana, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection
por: Šamadan, Lara, et al.
Publicado: (2021)

Distinct Cytokine Profiles in Severe COVID-19 and Non-Alcoholic Fatty Liver Disease
por: Papic, Neven, et al.
Publicado: (2022)

Liver involvement during influenza infection: perspective on the 2009 influenza pandemic
por: Papic, Neven, et al.
Publicado: (2011)

The association of semaphorins 3C, 5A and 6D with liver fibrosis stage in chronic hepatitis C
por: Papic, Neven, et al.
Publicado: (2018)

TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study
por: Susak, Frano, et al.
Publicado: (2023)

Emergence of Echinococcus multilocularis in Central Continental Croatia: A Human Case Series and Update on Prevalence in Foxes
por: Balen Topić, Mirjana, et al.
Publicado: (2023)

A retrospective comparison between influenza and COVID-19-associated ARDS in a Croatian tertiary care center
por: Gjurašin, Branimir, et al.
Publicado: (2020)

Clinical and Laboratoy Characteristics of Parvovirus B19 Infection During 2013/2014 Outbreak in Zagreb, Croatia
por: Ajdukovic, Mia, et al.
Publicado: (2017)

145. Liver Steatosis as a Risk Factor for Invasive Group B Streptococcus Infection in Non-Pregnant Adults
por: Papic, Neven, et al.
Publicado: (2019)

COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study
por: Močibob, Loris, et al.
Publicado: (2022)

Intravenous Drug Users Can Achieve a High Sustained Virological Response Rate: experience From Croatian Reference Center for Viral Hepatitis
por: Kurelac, Ivan, et al.
Publicado: (2011)

2411. One Dose Vancomycin Prophylaxis for In-Hospital Clostridioides difficile - Associated Disease
por: Papic, Neven, et al.
Publicado: (2019)

Systemic Cat Scratch Disease in Immunocompetent Adults: A Retrospective Case Series
por: Gjurasin, Branimir, et al.
Publicado: (2017)

The Impact of Nonalcoholic Fatty Liver Disease on Severe Community-Acquired Pneumonia Outcomes
por: Gjurašin, Branimir, et al.
Publicado: (2022)

Trends of Late Presentation to Care in Patients with Chronic Hepatitis C during a 10-Year Period in Croatia
por: Papic, Neven, et al.
Publicado: (2020)

Treatment of Elderly Patients with Chronic Hepatitis C: A Retrospective Cohort Study
por: Papić, Neven, et al.
Publicado: (2018)

Human Alveolar Echinococcosis, Croatia
por: Dušek, Davorka, et al.
Publicado: (2020)

The semaphorins
por: Yazdani, Umar, et al.
Publicado: (2006)

Combined Albenazole-Praziquantel Treatment in Recurrent Brain Echinococcosis: Case Report
por: SKUHALA, Tomislava, et al.
Publicado: (2019)

Treatment of chronic hepatitis C in Croatian war veterans: experiences from Croatian reference center for viral hepatitis
por: Papić, Neven, et al.
Publicado: (2011)

Regulation of immune cell responses by semaphorins and their receptors
por: Kumanogoh, Atsushi, et al.
Publicado: (2012)

Semaphorins as Potential Immune Therapeutic Targets for Cancer
por: Jiang, Jun, et al.
Publicado: (2022)

Long-term Outcomes of Acute Aseptic Encephalitis In Adults - a Single Center Study
por: Kusulja, Marija, et al.
Publicado: (2017)

Etiology and Outcomes of Healthcare-Associated Meningitis and Ventriculitis—A Single Center Cohort Study
por: Panic, Hana, et al.
Publicado: (2022)

299. Distinct TGF-β1 Patterns in Patients with Sepsis and Non-alcoholic Fatty Liver Disease
por: Papic, Neven, et al.
Publicado: (2023)

Semaphorins in immune cell function, inflammatory and infectious diseases
por: Thomas, Rony, et al.
Publicado: (2023)

Semaphorin Signaling in Cancer-Associated Inflammation
por: Franzolin, Giulia, et al.
Publicado: (2019)

Neuroimmune semaphorin 4A downregulates the severity of allergic response
por: Nkyimbeng-Takwi, EH, et al.
Publicado: (2012)

Semaphorins—not just for axons
por: LeBrasseur, Nicole
Publicado: (2002)

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)
por: Vadasz, Zahava, et al.
Publicado: (2015)

Semaphorin 3A in the Immune System: Twenty Years of Study
por: Kiseleva, Ekaterina P., et al.
Publicado: (2022)

Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma
por: Jiang, Jun, et al.
Publicado: (2022)

Successful Inhibition of Tumor Development by Specific Class-3 Semaphorins Is Associated with Expression of Appropriate Semaphorin Receptors by Tumor Cells
por: Kigel, Boaz, et al.
Publicado: (2008)

The Role of Semaphorins and Their Receptors in Gliomas
por: Law, Janice Wai Sze, et al.
Publicado: (2012)

Semaphorins and Their Receptors in Hematological Malignancies
por: Wei, Li, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bieh0oe771nsbo78h8moadjre8